The device is placed under the conjunctiva and attached to the sclera. The cup gradually diffuses the drug through the sclera and to the retina and vitreous, just like an organ-specific transdermal skin patch.
3T opthalmics Develops Protocols For Human Clinical Trials Of Episcleral Drug Delivery Device
